> Teva ($TEVA) received FDA approval for its Qvar inhaler with a dose counter to treat asthma. Release
> Oxford University announced plans for a new research center, The Oxford Centre for Drug Delivery Devices. Release
> Equashield announced FDA clearance of its eponymous first and second generation closed systems to minimize exposure to hazardous drugs. Release
> FDA agreed to review Mallinckrodt's ($MNK) New Drug Application for its extended-release oral formulation of hydrocodone and acetaminophen for pain management. Release